H. Szeto

H. Szeto, G. Dwyer, Y. Noguchi, 1989, Images of the Twenty-First Century. Proceedings of the Annual International Engineering in Medicine and Biology Society,.

Novel Therapies Targeting Inner Mitochondrial Membrane—From Discovery to Clinical Development

H. Szeto, P. Schiller, 2011, Pharmaceutical Research.

Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy.

P. Rabinovitch, H. Szeto, Dao-Fu Dai, 2011, Journal of the American College of Cardiology.

Development of Mitochondria‐targeted Aromatic‐cationic Peptides for Neurodegenerative Diseases

H. Szeto, 2008, Annals of the New York Academy of Sciences.

Cytoplasmic vacuolization responses to cytopathic bovine viral diarrhoea virus

H. Szeto, R. Donis, L. Cohen-Gould, 2007, Virus Research.

Disruption of cytochrome c heme coordination is responsible for mitochondrial injury during ischemia.

H. Szeto, Y. Soong, Shaoyi Liu, 2015, Biochimica et biophysica acta.

A highly potent peptide analgesic that protects against ischemia-reperfusion-induced myocardial stunning.

H. Szeto, Dunli Wu, Y. Soong, 2002, American journal of physiology. Heart and circulatory physiology.

Dynorphin and the hypothalamo-pituitary-adrenal axis during fetal development.

H. Szeto, 2003, Life sciences.

Cell-permeable, mitochondrial-targeted, peptide antioxidants

H. Szeto, 2006, The AAPS Journal.

Characterization of Acute and Chronic Neuropathies Induced by Oxaliplatin in Mice and Differential Effects of a Novel Mitochondria-targeted Antioxidant on the Neuropathies

Y. Ishida, H. Szeto, M. Shimoyama, 2014, Anesthesiology.

Crosstalk between autophagy and oxidative stress regulates proteolysis in the diaphragm during mechanical ventilation

S. Powers, A. Kavazis, M. Sandri, 2018, Free radical biology & medicine.

Meperidine pharmacokinetics in the maternal-fetal unit.

H. Szeto, C. Inturrisi, L. Mann, 1978, The Journal of pharmacology and experimental therapeutics.

APOL1 Risk Variants Affect Podocyte Lipid Homeostasis and Energy Production in Focal Segmental Glomerulosclerosis.

F. Fontanesi, A. Mendez, A. Fornoni, 2021, Human molecular genetics.

Mitochondria-targeted antioxidants protect against mechanical ventilation-induced diaphragm weakness*

S. Powers, A. Kavazis, H. Szeto, 2011, Critical care medicine.

Mitoprotective therapy prevents rapid, strain‐dependent mitochondrial dysfunction after articular cartilage injury

L. Bonassar, I. Cohen, H. Szeto, 2019, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Resensitization of Blood Pressure Response to &mgr;-Opioid Peptide Agonists After Acute Desensitization

H. Szeto, Dunli Wu, Y. Soong, 2001, Anesthesia and analgesia.

during mechanical ventilation Diaphragmatic nitric oxide synthase is not induced

S. Powers, A. Kavazis, H. Szeto, 2015 .

Mitochondrial Pharmacology: Its Future Is Now

H. Szeto, A. Atkinson, L. James, 2014, Clinical pharmacology and therapeutics.

The relationship between maternal and fetal plasma protein binding of methadone in the ewe during the third trimester.

H. Szeto, J. Umans, H. Umans, 1982, Life sciences.

Increased mitochondrial emission of reactive oxygen species and calpain activation are required for doxorubicin‐induced cardiac and skeletal muscle myopathy

S. Powers, A. Kavazis, H. Szeto, 2015, The Journal of physiology.

Mitochondria targeted peptides protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.

M. Beal, Lichuan Yang, H. Szeto, 2009, Antioxidants & redox signaling.

Targeting Mitochondria by SS-31 Ameliorates the Whole Body Energy Status in Cancer- and Chemotherapy-Induced Cachexia

T. M. O’Connell, H. Szeto, P. Costelli, 2021, Cancers.

Reduction of elevated proton leak rejuvenates mitochondria in the aged cardiomyocyte

Weiqi Wang, P. Rabinovitch, D. Marcinek, 2020, bioRxiv.

Protective Effect of a Mitochondria-Targeted Peptide against the Development of Chemotherapy-Induced Peripheral Neuropathy in Mice.

H. Szeto, P. Schiller, M. Shimoyama, 2018, ACS chemical neuroscience.

Serendipity and the Discovery of Novel Compounds That Restore Mitochondrial Plasticity

H. Szeto, A. Birk, 2014, Clinical pharmacology and therapeutics.

Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis

H. Szeto, J. Warren, A. Birk, 2014 .

Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines.

H. Szeto, S. Giannelli, Kesheng Zhao, 2005, Biochemical pharmacology.

Transcellular Transport of a Highly Polar 3+ Net Charge Opioid Tetrapeptide

H. Szeto, P. Schiller, Kesheng Zhao, 2003, Journal of Pharmacology and Experimental Therapeutics.

Do mitochondriotropic antioxidants prevent chlorinative stress-induced mitochondrial and cellular injury?

M. Whiteman, J. Spencer, H. Szeto, 2008, Antioxidants & redox signaling.

Role of extracellular ATP metabolism in regulation of platelet reactivity.

M. J. Broekman, A. Marcus, H. Szeto, 2002, The Journal of laboratory and clinical medicine.

Role of a novel soluble nucleotide phospho-hydrolase from sheep plasma in inhibition of platelet reactivity: hemostasis, thrombosis, and vascular biology.

M. J. Broekman, A. Marcus, H. Szeto, 2002, The Journal of laboratory and clinical medicine.

Doxorubicin-Induced Oxidative Stress Differentially Regulates Proteolytic Signaling in Cardiac and Skeletal Muscle.

H. Szeto, A. Smuder, Kisuk Min, 2019, American journal of physiology. Regulatory, integrative and comparative physiology.

Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury.

H. Szeto, S. Seshan, Dunli Wu, 2011, Journal of the American Society of Nephrology : JASN.

Pharmacologic Approaches to Improve Mitochondrial Function in AKI and CKD.

H. Szeto, 2017, Journal of the American Society of Nephrology : JASN.

Protection of mitochondria prevents high-fat diet-induced glomerulopathy and proximal tubular injury.

G. Prusky, N. Alam, H. Szeto, 2016, Kidney international.

Structure-activity relationships of mitochondria-targeted tetrapeptide pharmacological compounds

Eric R. May, A. Alexandrescu, H. Szeto, 2022, eLife.

A report consensus statements of the international society of Nephrology 2004 consensus workshop on prevention of progression of renal disease

R. Atkins, W. Mitch, P. Li, 2004 .

Physiologic variability and fetal electrocortical activity.

H. Szeto, R. Abrams, J. Clapp, 1980, American journal of obstetrics and gynecology.

Pharmacological targeting of mitochondrial function and reactive oxygen species production prevents colon 26 cancer-induced cardiorespiratory muscle weakness

D. Fuller, B. Roberts, A. Judge, 2020, Oncotarget.

Dual action of morphine on fetal breathing movements.

H. Szeto, Y. S. Zhu, J. Umans, 1988, The Journal of pharmacology and experimental therapeutics.

Mitochondrial targeting with antioxidant peptide SS-31 prevents mitochondrial depolarization, reduces islet cell apoptosis, increases islet cell yield, and improves posttransplantation function.

Dolca Thomas, Hua Yang, V. Sharma, 2007, Journal of the American Society of Nephrology : JASN.

Mitochondria-targeted antioxidant promotes recovery of skeletal muscle mitochondrial function after burn trauma assessed by in vivo 31 P nuclear magnetic resonance and electron paramagnetic resonance spectroscopy

R. Tompkins, A. Tzika, D. Mintzopoulos, 2013 .

Evaluation of SS-31 as a Potential Strategy for Tendinopathy Treatment: An In Vitro Model

S. Rodeo, H. Szeto, Xiang-Hua Deng, 2022, The American journal of sports medicine.

Cigarette smoke and reactive oxygen species metabolism: Implications for the pathophysiology of Reinke's edema

D. Kraus, L. Sulica, H. Szeto, 2009, The Laryngoscope.

Interaction between ATP and catecholamines in stimulation of platelet aggregation.

H. Szeto, Endri Leno, A. Birk, 2003, American journal of physiology. Heart and circulatory physiology.

Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.

G. Guillon, S. Stoev, M. Manning, 2007, Journal of medicinal chemistry.

[1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors.

G. Guillon, S. Stoev, M. Manning, 2002, Endocrinology.

ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes.

V. Nair, M. Kretzler, R. Nelson, 2019, The Journal of clinical investigation.

A novel cell-permeable antioxidant peptide decreases renal tubular apoptosis and damage in unilateral ureteral obstruction.

D. Poppas, H. Szeto, D. Felsen, 2008, American journal of physiology. Renal physiology.

Mitochondria Protection after Acute Ischemia Prevents Prolonged Upregulation of IL-1β and IL-18 and Arrests CKD.

L. Feldman, H. Szeto, L. Cohen-Gould, 2017, Journal of the American Society of Nephrology : JASN.

Immobilization-induced activation of key proteolytic systems in skeletal muscles is prevented by a mitochondria-targeted antioxidant.

S. Powers, H. Szeto, E. Talbert, 2013, Journal of applied physiology.

Highly potent fluorescent analogues of the opioid peptide [Dmt1]DALDA

H. Szeto, P. Schiller, B. Zelent, 2003, Peptides.

Endogenous Opioid Peptides Contribute to Antinociceptive Potency of Intrathecal [Dmt1]DALDA

H. Szeto, Dunli Wu, Y. Soong, 2003, Journal of Pharmacology and Experimental Therapeutics.

Profound Spinal Tolerance after Repeated Exposure to a Highly Selective μ-Opioid Peptide Agonist: Role of δ-Opioid Receptors

H. Szeto, P. Schiller, Dunli Wu, 2002 .

In vivo pharmacokinetics of selective mu-opioid peptide agonists.

H. Szeto, D. Desiderio, P. Schiller, 2001, The Journal of pharmacology and experimental therapeutics.

Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis.

M. Beal, S. Petri, H. Szeto, 2006, Journal of neurochemistry.

mitochondria-targeted antioxidant systems in skeletal muscles is prevented by a Immobilization-induced activation of key proteolytic

S. Powers, L. Koch, S. Britton, 2015 .

Zidovudine kinetics in the pregnant baboon.

R. Stark, H. Szeto, M. Myers, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

In vivo and in vitro models of ionizing radiation to the vocal folds

D. Kraus, H. Szeto, R. Ghossein, 2009, Head & neck.

Site and mechanism of action of dynorphin A-(1-13) and N-methyl-D-aspartate on ACTH release in fetal sheep.

D. Walker, H. Szeto, Dunli Wu, 2002, American journal of physiology. Endocrinology and metabolism.

SS-31 as a Mitochondrial Protectant in the Treatment of Tendinopathy

S. Rodeo, H. Szeto, Xiang-Hua Deng, 2022, The Journal of bone and joint surgery. American volume.

Differential respiratory effects of [Dmt1]DALDA and morphine in mice.

H. Szeto, A. Nakamura, Y. Fukuda, 2005, European journal of pharmacology.

U50,488H-induced pressor effect in the ovine foetus is mediated by sympathetic activation and vasopressin.

H. Szeto, Y. Soong, C. Taylor, 1996, European journal of pharmacology.

Precipitated opiate abstinence in utero.

H. Szeto, J. Umans, 1985, American journal of obstetrics and gynecology.

Current Concepts in Substance Abuse During Pregnancy

H. Szeto, 1990 .

Cardiovascular and respiratory actions of U50,488H in the unanaesthetized ovine foetus.

H. Szeto, Y. Soong, C. C. Taylor, 1996, European journal of pharmacology.

Antinociceptive and respiratory effects of intrathecal H-Tyr-D-Arg-Phe-Lys-NH2 (DALDA) and [Dmt1] DALDA.

N. Shimoyama, H. Szeto, P. Schiller, 2001, The Journal of pharmacology and experimental therapeutics.

Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer.

H. Szeto, C. Inturrisi, M. Reidenberg, 1977, Annals of internal medicine.

Superior Analgesic Effect of H‐Dmt‐D‐Arg‐Phe‐Lys‐NH2 ([Dmt1]DALDA), a Multifunctional Opioid Peptide, Compared to Morphine in a Rat Model of Neuropathic Pain

H. Szeto, P. Schiller, M. Shimoyama, 2012, Chemical biology & drug design.

Differential Analgesic Effects of a Mu-Opioid Peptide, [Dmt1]DALDA, and Morphine

Y. Tagaito, H. Szeto, P. Schiller, 2008, Pharmacology.

Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury.

H. Szeto, 2008, Antioxidants & redox signaling.

A potent opiate agonist protects against myocardial stunning during myocardial ischemia and reperfusion in rats

Jaeung Lee, M. Hong, S. C. Wong, 2005, Coronary artery disease.

Comparison of [Dmt1]DALDA and DAMGO in Binding and G Protein Activation at μ, δ, and κ Opioid Receptors

H. Szeto, P. Schiller, X. Qian, 2003, Journal of Pharmacology and Experimental Therapeutics.

DALDA AND DAMGO IN BINDING AND G PROTEIN ACTIVATION AT MU , DELTA AND KAPPA OPIOID RECEPTORS

H. Szeto, P. Schiller, X. Qian, 2003 .

COMPARISON OF [DMT]DALDA AND DAMGO IN BINDING AND G PROTEIN ACTIVATION AT MU, DELTA AND KAPPA OPIOID RECEPTORS

H. Szeto, P. Schiller, X. Qian, 2003 .

Amniotic Fluid Transfer of Meperidine From Maternal Plasma in Early Pregnancy

H. Szeto, L. Cederqvist, C. Inturrisi, 1978, Obstetrics and gynecology.

Baroreflex-mediated bradycardia is blunted by intravenous mu- but not kappa-opioid agonists.

H. Szeto, Y. Soong, D. Wu, 1998, Journal of cardiovascular pharmacology.

Cardiac aging: from molecular mechanisms to significance in human health and disease.

P. Rabinovitch, H. Szeto, Dao-Fu Dai, 2012, Antioxidants & redox signaling.

Quantitative analysis of [Dmt1]DALDA in ovine plasma by capillary liquid chromatography-nanospray ion-trap mass spectrometry

H. Szeto, D. Desiderio, P. Schiller, 2004 .

The development of electrocortical activity in the fetal and neonatal guinea pig.

H. Szeto, J. Umans, G. Senger, 1985, American journal of obstetrics and gynecology.

A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia

Lakshmi A. Devi, Hazel H. Szeto, J. Pintar, 2004 .

Structure-Activity Relationships in the Design of Mitochondria-Targeted Peptide Therapeutics

Eric R. May, A. Alexandrescu, H. Szeto, 2021, bioRxiv.

Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons.

P. Reddy, Byung S Park, M. Mańczak, 2010, Journal of Alzheimer's disease : JAD.

Mitochondrial oxidative stress in aging and healthspan

P. Rabinovitch, Y. Chiao, D. Marcinek, 2014, Longevity & healthspan.

Implications of the kinetics of zidovudine in the pregnant baboon following oral administration.

R. Stark, H. Szeto, M. Myers, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Placental Transfer and Fetal Metabolism of Zidovudine in the Baboon

R. Stark, H. Szeto, M. Myers, 1998, Pediatric Research.

The Primate Placenta is Permeable to Glucuronide Metabolites ♦ 334

R. Stark, H. Szeto, M. Garland, 1998, Pediatric Research.

A comparison of morphine and methadone disposition in the maternal-fetal unit.

H. Szeto, J. Umans, J. Mcfarland, 1982, American journal of obstetrics and gynecology.

The contribution of transplacental clearances and fetal clearance to drug disposition in the ovine maternal-fetal unit.

S. Rubinow, H. Szeto, J. Umans, 1982, Drug metabolism and disposition: the biological fate of chemicals.

A Novel Cell-permeable Antioxidant Peptide, SS31, Attenuates Ischemic Brain Injury by Down-regulating CD36*

H. Szeto, Sunghee Cho, Eunhee Kim, 2007, Journal of Biological Chemistry.

Prenatal development of sleep-wake patterns in sheep.

H. Szeto, D. Hinman, 1985, Sleep.

Effects of thyrotropin-releasing hormone in the fetal lamb.

H. Szeto, J. Umans, H. Umans, 1986, American journal of obstetrics and gynecology.

First‐in‐class cardiolipin‐protective compound as a therapeutic agent to restore mitochondrial bioenergetics

H. Szeto, 2014, British journal of pharmacology.

Behavioral states and their ontogeny: animal studies.

H. Szeto, 1992, Seminars in perinatology.

Pharmacological and physiological characterization of d[Leu4, Lys8]vasopressin, the first V1b-selective agonist for rat vasopressin/oxytocin receptors.

G. Guillon, S. Stoev, M. Manning, 2007, Endocrinology.

Design and synthesis of potent, highly selective vasopressin hypotensive agonists

S. Stoev, M. Manning, H. Szeto, 2006, Journal of peptide science : an official publication of the European Peptide Society.

RNA self-cleavage activated by ultraviolet light-induced oxidation

H. Szeto, I. Mena, Rosa Díaz-Toledano, 2011, Nucleic acids research.

Stealth Peptides Target Cellular Powerhouses to Fight Rare and Common Age-Related Diseases.

H. Szeto, 2019, Protein and peptide letters.

Cardiolipin-targeted peptides rejuvenate mitochondrial function, remodel mitochondria, and promote tissue regeneration during aging.

H. Szeto, Shaoyi Liu, 2018, Archives of biochemistry and biophysics.

Improving mitochondrial bioenergetics under ischemic conditions increases warm ischemia tolerance in the kidney.

H. Szeto, Y. Soong, Shaoyi Liu, 2015, American journal of physiology. Renal physiology.

Dynorphin A1-13 stimulates ovine fetal pituitary-adrenal function through a novel nonopioid mechanism.

H. Szeto, Dunli Wu, Y. Soong, 1997, The Journal of pharmacology and experimental therapeutics.

Opioid modulation of the fetal hypothalamic-pituitary-adrenal axis: the role of receptor subtypes and route of administration.

H. Szeto, Dunli Wu, Y. Soong, 1997, The Journal of pharmacology and experimental therapeutics.

Simultaneous determination of meperidine and normeperidine in biofluids.

H. Szeto, C. Inturrisi, 1976, Journal of chromatography.

Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban

S. Stoev, M. Manning, B. Mouillac, 2005, Journal of peptide science : an official publication of the European Peptide Society.

Differential sensitivities of fetal muscle groups to d-tubocurarine.

H. Szeto, D. Hinman, 1990, American journal of obstetrics and gynecology.

Cholinergic influences on sleep-wake patterns and breathing movements in the fetus.

H. Szeto, D. Hinman, 1988, The Journal of pharmacology and experimental therapeutics.

Cyclic variation in fetal heart rate and sympathetic activity.

H. Szeto, Y. S. Zhu, Y. Zhu, 1987, American journal of obstetrics and gynecology.

Baroreflex-mediated bradycardia but not tachycardia is blunted peripherally by intravenous mu-opioid agonists.

J. Clapp, H. Szeto, H. Kim, 1998, American journal of obstetrics and gynecology.

Mitochondrial-targeted antioxidants protect skeletal muscle against immobilization-induced muscle atrophy.

S. Powers, A. Kavazis, H. Szeto, 2011, Journal of applied physiology.

Mitochondria-Derived Reactive Oxygen Species Mediate Heme Oxygenase-1 Expression in Sheared Endothelial Cells

J. Zweier, H. Szeto, R. Giedt, 2009, Journal of Pharmacology and Experimental Therapeutics.

Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans.

P. Neufer, P. Rabinovitch, D. Wasserman, 2009, The Journal of clinical investigation.

A peripheral site of action for the attenuation of baroflex-mediated bradycardia by intravenous mu-opioid agonists.

J. Clapp, H. Szeto, Y. Soong, 2000, Journal of cardiovascular pharmacology.

The Role of the Merrifield Solid Phase Method in the Discovery and Exploration of a New Class of Selective Vasopressin Hypotensive Agonists

S. Stoev, M. Manning, H. Szeto, 2007, International Journal of Peptide Research and Therapeutics.

Nociceptin/orphanin FQ increases blood pressure and heart rate via sympathetic activation in sheep

H. Szeto, Dunli Wu, Y. Soong, 1999, Peptides.

A mitochondrial therapeutic reverses visual decline in mouse models of diabetes

Glen T. Prusky, Robert M. Douglas, Nazia M. Alam, 2015, Disease Models & Mechanisms.

Position 4 analogues of [deamino‐Cys1] arginine vasopressin exhibit striking species differences for human and rat V2/V1b receptor selectivity

G. Guillon, S. Stoev, M. Manning, 2006, Journal of peptide science : an official publication of the European Peptide Society.

The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin.

H. Szeto, P. Singh, S. Seshan, 2013, Journal of the American Society of Nephrology : JASN.

Kinetics of Drug Transfer to the Fetus

H. Szeto, 1993, Clinical obstetrics and gynecology.

Morphine-induced tachycardia in fetal lambs: a bell-shaped dose-response curve.

H. Szeto, Y. S. Zhu, 1989, The Journal of pharmacology and experimental therapeutics.

Cell‐permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis

M. Beal, S. Petri, H. Szeto, 2006 .

Dynorphin Stimulates Corticotropin Release from Mouse Anterior Pituitary AtT-20 Cells through Nonopioid Mechanisms

M. Gershengorn, H. Szeto, A. Birk, 2000, Neuroendocrinology.

The Role of N-Methyl-D-Aspartate Receptors in the Release of Adrenocorticotropin by Dynorphin A1–13

H. Szeto, Dunli Wu, Y. Soong, 1999, Neuroendocrinology.

Dynorphin A 1–13 Stimulates Ovine Fetal Pituitary-Adrenal Function through a Novel Nonopioid Mechanism 1

H. Szeto, Y. Soong, J. Yee, 1997 .

Fluorescent dyes alter intracellular targeting and function of cell‐penetrating tetrapeptides

H. Szeto, P. Schiller, Kesheng Zhao, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Maternal‐Fetal Pharmacokinetics and Fetal Dose‐Response Relationships

H. Szeto, 1989, Annals of the New York Academy of Sciences.

Opioid modulation of fetal glucose homeostasis: role of receptor subtypes.

H. Szeto, Y. Soong, D. Wu, 1995, Journal of Pharmacology and Experimental Therapeutics.

Morphine Stimulates Adrenocorticotropin and Cortisol Release in the Late-Term Ovine Fetus

H. Szeto, Dunli Wu, Y. Soong, 1997, Pediatric Research.

Prenatal morphine exposure and sleep-wake disturbances in the fetus.

H. Szeto, Y. S. Zhu, S. Clare, 1988, Sleep.

Disposition of methadone in the ovine maternal-fetal unit.

H. Szeto, J. Clapp, C. Inturrisi, 1981, Life sciences.

Automated Identification and Quantitation of Four Patterns of Electrocortical Activity in the Near-Term Fetal Lamb

H. Szeto, M. McNerney, 1990, Pediatric Research.

Spectral Edge Frequency as a Simple Quantitative Measure of the Maturation of Electrocortical Activity

H. Szeto, Hazel H Szeto, 1990, Pediatric Research.

The ontogeny of fetal lamb electrocortical activity: a power spectral analysis.

H. Szeto, G. Dwyer, G. Senger, 1985, American journal of obstetrics and gynecology.

Molecular Mechanism of Action of Mitochondrial Therapeutic SS-31 (Elamipretide): Membrane Interactions and Effects on Surface Electrostatics

Eric R. May, Xianlin Han, H. Szeto, 2019, bioRxiv.

Global Proteomics and Pathway Analysis of Pressure-Overload–Induced Heart Failure and Its Attenuation by Mitochondrial-Targeted Peptides

M. MacCoss, P. Rabinovitch, R. Beyer, 2012, Circulation. Heart failure.

Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis

H. Szeto, J. Warren, A. Birk, 2014, British journal of pharmacology.

Chapter 17 – Cardiac Aging

R. Bodmer, P. Rabinovitch, Y. Chiao, 2016 .

Comparison of [Dmt 1 ]DALDA and DAMGO in Binding and G Protein Activation at (cid:1) , (cid:2) , and (cid:3) Opioid Receptors

H. Szeto, P. Schiller, X. Qian, 2003 .

Profound spinal tolerance after repeated exposure to a highly selective mu-opioid peptide agonist: role of delta-opioid receptors.

H. Szeto, P. Schiller, Dunli Wu, 2002, The Journal of pharmacology and experimental therapeutics.

Respiratory depression after intravenous administration of δ-selective opioid peptide analogs

J. Clapp, H. Szeto, Dunli Wu, 1999, Peptides.

Respiratory depression after intravenous administration of delta-selective opioid peptide analogs.

J. Clapp, H. Szeto, Y. Soong, 1999, Peptides.

Investigating the effects of opioid drugs on electrocortical activity using wavelet transform

Metin Akay, Peter Cheng, Yasemin M. Akay, 1995, Biological Cybernetics.

The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action

Eric R. May, Xianlin Han, H. Szeto, 2020, The Journal of Biological Chemistry.

The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action.

Eric R. May, Xianlin Han, H. Szeto, 2020, The Journal of biological chemistry.

Diurnal variation in continuous measures of the rat EEG power spectra

K. Grasing, H. Szeto, Kenneth Grasing, 1992, Physiology & Behavior.

Plasma delta-9-tetrahydrocannabinol in pregnant sheep and fetus after inhalation of smoke from a marijuana cigarette.

K. Niederreither, H. Szeto, R. Abrams, 1985, Alcohol and drug research.

Urinary excretion of meperidine by the fetal lamb.

J. Clapp, H. Szeto, C. Inturrisi, 1979, The Journal of pharmacology and experimental therapeutics.

Cardiovascular and metabolic responses to two receptor-selective opioid agonists in pregnant sheep.

J. Clapp, H. Szeto, H. Kim, 1998, American journal of obstetrics and gynecology.

10 – Effects of Opiates on the Physiology of the Fetal Nervous System

H. Szeto, P. Cheng, 1992 .

A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia.

Lakshmi A Devi, J. Pintar, H. Szeto, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Fetal metabolic response to experimental placental vascular damage.

H. Szeto, J. Clapp, L. Mann, 1981, American journal of obstetrics and gynecology.

Umbilical blood flow response to embolization of the uterine circulation.

H. Szeto, J. Clapp, L. Mann, 1980, American journal of obstetrics and gynecology.

atrophy muscle against immobilization-induced muscle Mitochondrial-targeted antioxidants protect skeletal

C. Franklin, S. Powers, A. Kavazis, 2015 .

Altered diurnal pattern of arousal following naloxone administration in opioid-naive rats

K. Grasing, H. Szeto, 1990, Behavioural Brain Research.

EEG changes with different levels of morphine self-administration

K. Grasing, H. Szeto, 1993, Neuropharmacology.

The Effects of Selective mu1 Opiate Receptor Blockade on Breathing Patterns in the Fetal Lamb

H. Szeto, Dunli Wu, Y. Cheng, 1991, Pediatric Research.

Opioid-induced stimulation of fetal respiratory activity by [D-Ala2]deltorphin I.

H. Szeto, Y. Soong, D. Wu, 1993, European journal of pharmacology.

Morphine-induced stimulation of fetal breathing: role of mu 1-receptors and central muscarinic pathways.

H. Szeto, H H Szeto, P Y Cheng, 1991, The American journal of physiology.

Morphine-induced activation of fetal EEG is mediated via central muscarinic pathways.

H. Szeto, 1991, The American journal of physiology.

Maternal marijuana smoking alters respiratory timing in the fetal lamb

H. Szeto, Dunli Wu, Yi Cheng, 1992, Pharmacology Biochemistry and Behavior.

Effects of single and repeated marijuana smoke exposure on fetal EEG

H. Szeto, Dunli Wu, Yi Cheng, 1991, Pharmacology Biochemistry and Behavior.

Differential mechanisms of ovine fetal pituitary stimulation by a selective kappa-opioid agonist and by dynorphin.

H. Szeto, Y. Soong, C. C. Taylor, 1996, Neuroendocrinology.

kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor.

H. Szeto, Y. Soong, C. C. Taylor, 1996, Journal of Pharmacology and Experimental Therapeutics.

Effects of the δ-opioid agonist, [D-Pen2, D-Pen5]-enkephalin, on fetal lamb EEG

H. Szeto, Dunli Wu, Y. Soong, 1994, Pharmacology Biochemistry and Behavior.

Central muscarinic modulation of fetal blood pressure and heart rate.

H. Szeto, D. Hinman, 1990, Journal of developmental physiology.

Targeting CD36‐Mediated Inflammation Reduces Acute Brain Injury in Transient, but not Permanent, Ischemic Stroke

Eun-Hee Kim, H. Szeto, Sunghee Cho, 2015, CNS neuroscience & therapeutics.

Nonlinear Control of Breathing Activity in Early Development

H. Szeto, 1996 .

Effects of narcotic drugs on fetal behavioral activity: acute methadone exposure.

H. Szeto, 1983, American journal of obstetrics and gynecology.

Brain uptake of meperidine in the fetal lamb.

H. Szeto, R. Abrams, J. Clapp, 1980, American journal of obstetrics and gynecology.

Cardiovascular effects of a μ-selective opioid agonist (tyrosine-D-arginine-phenylalanine-lysine-NH2) in fetal sheep: Sites and mechanisms of action

H. Szeto, Dunli Wu, Y. Soong, 1999 .

In vivo disposition of dermorphin analog (DALDA) in nonpregnant and pregnant sheep.

R. Becklin, J. Clapp, H. Szeto, 1998, The Journal of pharmacology and experimental therapeutics.

Central opioid modulation of fetal cardiovascular function: role of mu- and delta-receptors.

H. Szeto, Y. S. Zhu, L. Cai, 1990, The American journal of physiology.

The effects of morphine on the relationship between fetal EEG, breathing and blood pressure signals using fast wavelet transform

Metin Akay, Yasemin M. Akay, Hazel H. Szeto, 1996, Biological Cybernetics.

Time-frequency analysis of the electrocortical activity during maturation using wavelet transform

Metin Akay, Peter Cheng, Yasemin M. Akay, 1994, Biological Cybernetics.

Effects of opiates on fetal behavioral activity in utero.

H. Szeto, J. Umans, 1983, Life sciences.

Central opioid modulation of breathing dynamics in the fetal lamb: effects of [D-Pen2,D-Pen5]-enkephalin and partial antagonism by naltrindole.

H. Szeto, D. Wu, Y. Cheng, 1992, The Journal of pharmacology and experimental therapeutics.

Novel cardiolipin therapeutic protects endothelial mitochondria during renal ischemia and mitigates microvascular rarefaction, inflammation, and fibrosis.

H. Szeto, S. Seshan, Y. Soong, 2014, American journal of physiology. Renal physiology.

Improving mitochondrial bioenergetics under ischemic conditions increases warm ischemia tolerance in the kidney.

H. Szeto, Y. Soong, Shaoyi Liu, 2015, American journal of physiology. Renal physiology.

ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes.

V. Nair, M. Kretzler, R. Inagi, 2019, The Journal of clinical investigation.

Nonlinear investigation of developmental changes of the ECoG activity in fetal sheep

H. Szeto, M. Schwab, K. Schmidt, 1998, Proceedings of the 20th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. Vol.20 Biomedical Engineering Towards the Year 2000 and Beyond (Cat. No.98CH36286).

A Mitochondrial-targeted Antioxidant Protects against Mechanical Ventilation-induced Diaphragm Weakness

S. Powers, A. Kavazis, H. Szeto, 2010 .

Neuropathology in the chronic fetal lamb preparation: structure-function correlates under different environmental conditions.

J. Clapp, H. Szeto, N. Peress, 1981, American journal of obstetrics and gynecology.

Fractal properties in fetal breathing dynamics.

H. Szeto, H H Szeto, P Y Cheng, 1992, The American journal of physiology.